Keefe RSE - Search Results

1

Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms: Results From a Randomized Controlled Trial.

Keefe RSE, Harvey PD, Khan A, Saoud JB, Staner C, Davidson M, Luthringer R. Keefe RSE, et al. J Clin Psychiatry. 2018 May/Jun;79(3):17m11753. doi: 10.4088/JCP.17m11753. J Clin Psychiatry. 2018. PMID: 29873956 Free article. Clinical Trial.

2

Measurements of plasma homovanillic acid in schizophrenic patients.

Davidson M, Kahn RS, Stern RG, Harvey PD, Keefe R, Knott P, Apter S, Webster L, Davis KL. Davidson M, et al. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:521A-522A. doi: 10.1097/00002826-199201001-00271. Clin Neuropharmacol. 1992. PMID: 1354058 No abstract available.

3

Empirical assessment of the factorial structure of clinical symptoms in schizophrenic patients: formal thought disorder.

Harvey PD, Lenzenweger MF, Keefe RS, Pogge DL, Serper MR, Mohs RC. Harvey PD, et al. Psychiatry Res. 1992 Nov;44(2):141-51. doi: 10.1016/0165-1781(92)90048-8. Psychiatry Res. 1992. PMID: 1480679

4

Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms.

Keefe RS, Harvey PD, Lenzenweger MF, Davidson M, Apter SH, Schmeidler J, Mohs RC, Davis KL. Keefe RS, et al. Psychiatry Res. 1992 Nov;44(2):153-65. doi: 10.1016/0165-1781(92)90049-9. Psychiatry Res. 1992. PMID: 1480680

5

Brief neuroleptic discontinuation and clinical symptoms in Kraepelinian and non-Kraepelinian chronic schizophrenic patients.

Harvey PD, Putnam KM, Davidson M, Kahn RS, Powchik P, McQueeney R, Keefe RS, Davis KL. Harvey PD, et al. Psychiatry Res. 1991 Sep;38(3):285-92. doi: 10.1016/0165-1781(91)90018-k. Psychiatry Res. 1991. PMID: 1684442

6

Diagnostic issues in chronic schizophrenia: kraepelinian schizophrenia, undifferentiated schizophrenia, and state-independent negative symptoms.

Keefe RS, Lobel DS, Mohs RC, Silverman JM, Harvey PD, Davidson M, Losonczy MF, Davis KL. Keefe RS, et al. Schizophr Res. 1991 Mar-Apr;4(2):71-9. doi: 10.1016/0920-9964(91)90026-n. Schizophr Res. 1991. PMID: 2039764

7

Attentional markers of vulnerability to schizophrenia: performance of medicated and unmedicated patients and normals.

Harvey PD, Keefe RS, Moskowitz J, Putnam KM, Mohs RC, Davis KL. Harvey PD, et al. Psychiatry Res. 1990 Aug;33(2):179-88. doi: 10.1016/0165-1781(90)90072-d. Psychiatry Res. 1990. PMID: 2243895

8

Eye tracking impairment in clinically identified patients with schizotypal personality disorder.

Siever LJ, Keefe R, Bernstein DP, Coccaro EF, Klar HM, Zemishlany Z, Peterson AE, Davidson M, Mahon T, Horvath T, et al. Siever LJ, et al. Am J Psychiatry. 1990 Jun;147(6):740-5. doi: 10.1176/ajp.147.6.740. Am J Psychiatry. 1990. PMID: 2343917

9

L-dopa challenge and relapse in schizophrenia.

Davidson M, Keefe RS, Mohs RC, Siever LJ, Losonczy MF, Horvath TB, Davis KL. Davidson M, et al. Am J Psychiatry. 1987 Jul;144(7):934-8. doi: 10.1176/ajp.144.7.934. Am J Psychiatry. 1987. PMID: 2886063

10

Premorbid sociosexual functioning and long-term outcome in schizophrenia.

Keefe RS, Mohs RC, Losonczy MF, Davidson M, Silverman JM, Horvath TB, Davis KL. Keefe RS, et al. Am J Psychiatry. 1989 Feb;146(2):206-11. doi: 10.1176/ajp.146.2.206. Am J Psychiatry. 1989. PMID: 2912262

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters